AMG-780

N/A

Report date: 2022/07/19 20:00:45

Base Information

Drug NameAMG-780

Drug Alias NameAMG-780

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human

Mechanisms of ActionAngiopoietin-1 inhibitorsAngiopoietin-2 inhibitors

TargetsAngiopoietin-2Angiopoietin-1

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesAmgen Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAmgen Inc

Active IndicationsN/A

Inactive IndicationsSolid tumours

ATC CodeN/A